Open AccessNeuroleptic-Induced Brugada Syndrome - A Case Report
Author(s) -
Fouad Laboudi,
Ghizlane Slimani,
Mohamed Essaid Gourani,
Abderrazzak Ouanass
Publication year - 2018
Publication title -
integrative journal of medical sciences
Language(s) - English
Resource type - Journals
ISSN - 2658-8218
DOI - 10.15342/ijms.v5ir.189
Subject(s) - brugada syndrome , medicine , amiodarone , penetrance , cardiology , sudden death , sudden cardiac death , st elevation , electrocardiography , atrial fibrillation , biochemistry , chemistry , gene , phenotype
Brugada syndrome is a rare genetic disease, of autosomal dominant inheritance with low penetrance, manifested by ST-segment elevation at right precordial V1, V2, and V3, and right branch block aspect. to the electrocardiogram. It exposes to a high risk of ventricular arrhythmia that can cause syncope and even sudden death, on a structurally healthy heart.We report here the case of a young patient of 25 years who has a syndrome of Brugada induced by a neuroleptic. To our knowledge, this is the first reported case of Brugada syndrome induced by a neuroleptic Morocco. Therapeutic management is based on Amiodarone and beta-blockers. Regular monitoring of the ECG should, however, be performed on patients taking psychotropic drugs and also on associations.